Notably, cyclin-dependent kinase inhibitor 2A (CDKN2A) and L1 cell adhesion molecule (L1CAM) hypermethylation correlates with tumor progression and invasiveness (Weiss et al., 2022; Ogiwara and Kohno, 2012). Here, CDKN2A is linked to neoplasm.